ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ORIC

Stock NameOric Pharmaceuticals Inc
TickerORIC(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS68622P1093
LEI54930033FJRNEYBW0L25

Show aggregate ORIC holdings

News associated with ORIC

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Moderate Buy” from Analysts
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target […] - 2025-09-19 03:15:02
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $17.63
Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month […] - 2025-08-28 03:12:47
JPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price
Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) had its price target decreased by JPMorgan Chase & Co. from $20.00 to $17.00 in a research report sent to investors on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. ORIC has been the subject of a number of other reports. Oppenheimer lowered […] - 2025-08-15 04:52:49
Victory Capital Management Inc. Has $838,000 Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)
Victory Capital Management Inc. raised its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 150,260 shares of the company’s stock after buying an additional 52,760 shares during the period. Victory Capital Management Inc.’s […] - 2025-08-01 05:01:17
Arizona State Retirement System Purchases New Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)
Arizona State Retirement System purchased a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the first quarter, Holdings Channel reports. The institutional investor purchased 10,088 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds have also modified their holdings of ORIC. Vanguard Group Inc. increased its […] - 2025-07-24 04:38:53
LADENBURG THALM/SH SH Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC)
LADENBURG THALM/SH SH assumed coverage on shares of Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Several other equities research analysts have also recently weighed in on ORIC. Oppenheimer decreased their price objective on Oric […] - 2025-07-11 02:36:47
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $19.17
Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have received an average rating of “Buy” from the nine brokerages that are covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on the stock […] - 2025-07-09 02:33:02
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up After Insider Buying Activity
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Tuesday following insider buying activity. The stock had previously closed at $10.00, but opened at $10.63. Oric Pharmaceuticals shares last traded at $10.87, with a volume of 484,723 shares. Specifically, Director Angie You acquired 26,597 shares of the firm’s stock […] - 2025-06-25 02:22:47
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.5% during the fourth quarter, Holdings Channel reports. The fund owned 35,579 shares of the company’s stock after purchasing an additional 12,545 shares during the quarter. UBS AM a […] - 2025-06-13 04:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of “Buy” by Analysts
Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have covered the stock […] - 2025-06-11 03:08:48
Thursday's ETF Movers: XBI, URA
In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Oric Pharmaceuticals, up about 33.8% and shares of Replimune Group, up about 9.6% on the day. And un - 2025-05-29 12:59:01
Janus Henderson Group PLC Makes New Investment in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
Janus Henderson Group PLC acquired a new stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 14,600 shares of the company’s stock, valued at approximately $118,000. Several other institutional investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a […] - 2025-05-26 04:51:01
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Target Price at $19.17
Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have updated their coverage on […] - 2025-05-22 05:30:55
Tower Research Capital LLC TRC Purchases 13,384 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
Tower Research Capital LLC TRC lifted its position in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 1,048.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,661 shares of the company’s stock after purchasing an additional 13,384 shares during the quarter. […] - 2025-05-09 05:21:00
MetLife Investment Management LLC Purchases 5,530 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
MetLife Investment Management LLC grew its position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,608 shares of the company’s stock after acquiring an additional 5,530 shares during the period. MetLife Investment […] - 2025-05-07 05:28:51
HC Wainwright Reiterates Buy Rating for ORIC Pharmaceuticals (NASDAQ:ORIC)
ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $21.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 316.67% from the stock’s previous close. Other analysts […] - 2025-05-07 02:58:49
XTX Topco Ltd Has $210,000 Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)
XTX Topco Ltd increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 120.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,966 shares of the company’s stock after acquiring an additional 14,209 shares during the period. XTX […] - 2025-04-28 05:11:12
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) PT at $18.86
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the last year […] - 2025-04-25 02:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Wellington Management Group LLP
Wellington Management Group LLP increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 6.9% during the fourth quarter, HoldingsChannel reports. The fund owned 186,430 shares of the company’s stock after buying an additional 12,042 shares during the period. Wellington Management Group LLP’s holdings in ORIC Pharmaceuticals were worth $1,504,000 at […] - 2025-04-14 04:45:06
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.86 Consensus PT from Brokerages
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been assigned an average rating of “Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in […] - 2025-03-31 02:32:43
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Better-Than-Expected Earnings
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $7.85, but opened at $8.57. ORIC Pharmaceuticals shares last traded at $7.99, with a volume of 78,926 shares traded. The company reported ($0.51) EPS for the […] - 2025-02-21 04:56:45
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Buy” from Analysts
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average recommendation of “Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock in […] - 2025-02-11 06:30:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ORIC holdings

DateNumber of ORIC Shares HeldBase Market Value of ORIC SharesLocal Market Value of ORIC SharesChange in ORIC Shares HeldChange in ORIC Base ValueCurrent Price per ORIC Share HeldPrevious Price per ORIC Share Held
2025-12-24 (Wednesday)63,123USD 532,127ORIC holding increased by 10100USD 532,1270USD 10,100 USD 8.43 USD 8.27
2025-12-23 (Tuesday)63,123ORIC holding decreased by -1800USD 522,027ORIC holding decreased by -23326USD 522,027-1,800USD -23,326 USD 8.27 USD 8.4
2025-12-22 (Monday)64,923USD 545,353ORIC holding increased by 23372USD 545,3530USD 23,372 USD 8.4 USD 8.04
2025-12-19 (Friday)64,923ORIC holding decreased by -5484USD 521,981ORIC holding decreased by -47260USD 521,981-5,484USD -47,260 USD 8.04 USD 8.08501
2025-12-18 (Thursday)70,407USD 569,241ORIC holding decreased by -9505USD 569,2410USD -9,505 USD 8.08501 USD 8.22001
2025-12-17 (Wednesday)70,407ORIC holding decreased by -815USD 578,746ORIC holding decreased by -70799USD 578,746-815USD -70,799 USD 8.22001 USD 9.12
2025-12-16 (Tuesday)71,222ORIC holding decreased by -163USD 649,545ORIC holding decreased by -9339USD 649,545-163USD -9,339 USD 9.12 USD 9.23001
2025-12-15 (Monday)71,385ORIC holding increased by 326USD 658,884ORIC holding decreased by -7649USD 658,884326USD -7,649 USD 9.23001 USD 9.37999
2025-12-12 (Friday)71,059USD 666,533ORIC holding decreased by -22029USD 666,5330USD -22,029 USD 9.37999 USD 9.69
2025-12-11 (Thursday)71,059ORIC holding increased by 334USD 688,562ORIC holding decreased by -18688USD 688,562334USD -18,688 USD 9.69 USD 10
2025-12-10 (Wednesday)70,725USD 707,250ORIC holding decreased by -9902USD 707,2500USD -9,902 USD 10 USD 10.14
2025-12-09 (Tuesday)70,725USD 717,152ORIC holding decreased by -26875USD 717,1520USD -26,875 USD 10.14 USD 10.52
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ORIC by Blackrock for IE00BYXG2H39

Show aggregate share trades of ORIC

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-23SELL-1,8008.5658.190 8.227USD -14,809 9.17 Profit of 1,689 on sale
2025-12-19SELL-5,4848.2407.980 8.006USD -43,905 9.17 Profit of 6,406 on sale
2025-12-17SELL-8159.2308.200 8.303USD -6,767 9.18 Profit of 717 on sale
2025-12-16SELL-1639.4158.820 8.879USD -1,447 9.18 Profit of 50 on sale
2025-12-15BUY3269.5019.185 9.217USD 3,005 9.18
2025-12-11BUY33410.0909.645 9.690USD 3,236 9.18
2025-12-04BUY3,22011.54010.720 10.802USD 34,782 9.15
2025-12-02BUY2,43011.24510.445 10.525USD 25,576 9.13
2025-11-28BUY16212.14011.742 11.782USD 1,909 9.11
2025-11-26BUY48611.95011.460 11.509USD 5,593 9.08
2025-11-26BUY48611.95011.460 11.509USD 5,593 9.08
2025-11-25BUY81012.29011.470 11.552USD 9,357 9.07
2025-11-24BUY16212.00511.500 11.551USD 1,871 9.06
2025-11-20SELL-64412.50011.210 11.339USD -7,302 9.03 Loss of -1,485 on sale
2025-11-19BUY16112.04011.470 11.527USD 1,856 9.02
2025-11-18BUY96612.14511.510 11.574USD 11,180 9.01
2025-11-17BUY32212.71011.280 11.423USD 3,678 8.99
2025-11-14BUY16113.45012.135 12.266USD 1,975 8.98
2025-11-12BUY16112.96512.390 12.448USD 2,004 8.94
2025-11-10BUY16012.86012.330 12.383USD 1,981 8.91
2025-11-06BUY16012.91012.160 12.235USD 1,958 8.87
2025-11-04BUY16112.71012.160 12.215USD 1,967 8.83
2025-10-30BUY80513.51012.752 12.828USD 10,326 8.77
2025-10-29BUY32212.93013.570 13.506USD 4,349 8.74
2025-10-22SELL-64012.08012.562 12.514USD -8,009 8.63 Loss of -2,484 on sale
2025-10-20BUY32012.38013.070 13.001USD 4,160 8.59
2025-10-17BUY79912.78013.350 13.293USD 10,621 8.57
2025-10-15BUY1,27213.90014.040 14.026USD 17,841 8.54
2025-10-03BUY1,12711.56511.710 11.695USD 13,181 8.50
2025-10-02BUY16111.32011.839 11.787USD 1,898 8.48
2025-09-30BUY32212.00012.050 12.045USD 3,878 8.44
2025-09-26BUY32211.12011.220 11.210USD 3,610 8.41
2025-09-25BUY32210.41010.650 10.626USD 3,422 8.40
2025-09-24BUY11,46310.46010.820 10.784USD 123,617 8.38
2025-09-18BUY12911.00011.171 11.154USD 1,439 8.37
2025-09-17BUY38710.52011.160 11.096USD 4,294 8.36
2025-08-20SELL-5089.5109.635 9.623USD -4,888 8.31 Loss of -664 on sale
2025-07-30BUY50410.71011.330 11.268USD 5,679 8.25
2025-07-17SELL-25411.14011.570 11.527USD -2,928 8.07 Loss of -877 on sale
2025-07-16BUY2,55411.18011.380 11.360USD 29,013 8.05
2025-07-11SELL-96011.10011.420 11.388USD -10,932 7.99 Loss of -3,259 on sale
2025-07-07BUY36010.65010.860 10.839USD 3,902 7.91
2025-07-02BUY6,60010.65011.190 11.136USD 73,498 7.87
2025-06-11BUY2429.39010.040 9.975USD 2,414 7.78
2025-06-10BUY2429.75010.000 9.975USD 2,414 7.77
2025-06-04SELL-1229.0809.090 9.089USD -1,109 7.72 Loss of -167 on sale
2025-04-23BUY1235.1705.660 5.611USD 690 8.31
2025-04-10SELL-9844.3104.605 4.576USD -4,502 8.65 Profit of 4,014 on sale
2025-04-08SELL-1234.2554.990 4.916USD -605 8.75 Profit of 472 on sale
2025-04-07SELL-1224.5905.010 4.968USD -606 8.80 Profit of 467 on sale
2025-04-04SELL-6154.8805.180 5.150USD -3,167 8.85 Profit of 2,272 on sale
2025-04-01BUY4925.5305.680 5.665USD 2,787 8.92
2025-03-31SELL-3695.5805.890 5.859USD -2,162 8.96 Profit of 1,145 on sale
2025-03-21BUY3,0987.0307.470 7.426USD 23,006 9.15
2025-03-14SELL-1,8087.7907.960 7.943USD -14,361 9.26 Profit of 2,375 on sale
2025-03-07SELL-2268.0008.040 8.036USD -1,816 9.37 Profit of 301 on sale
2025-03-04SELL-1137.6607.790 7.777USD -879 9.44 Profit of 188 on sale
2025-02-25BUY2268.0808.120 8.116USD 1,834 9.57
2025-02-19SELL-1127.9408.570 8.507USD -953 9.71 Profit of 134 on sale
2025-02-13BUY3338.2709.640 9.503USD 3,164 9.83
2025-02-12BUY1119.4509.690 9.666USD 1,073 9.83
2025-02-11BUY4409.85011.720 11.533USD 5,075 9.83
2024-12-30SELL-3,7468.1708.290 8.278USD -31,009 9.42 Profit of 4,269 on sale
2024-11-18SELL-1,8038.5608.805 8.781USD -15,831 9.30 Profit of 940 on sale
2024-11-08SELL-12010.26010.290 10.287USD -1,234 9.17 Loss of -135 on sale
2024-10-21SELL-1229.1209.450 9.417USD -1,149 0.00 Loss of -1,149 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ORIC

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19312,2280401,87977.7%
2025-09-18189,6570290,97565.2%
2025-09-17196,60914,866429,15245.8%
2025-09-16274,4980389,94770.4%
2025-09-15387,5620505,21976.7%
2025-09-12251,3546,075360,70069.7%
2025-09-11237,2380345,07968.7%
2025-09-10189,6151,200348,87254.4%
2025-09-09202,5170489,46541.4%
2025-09-08190,42913673,70628.3%
2025-09-05220,3810414,07153.2%
2025-09-04304,8201,583396,66676.8%
2025-09-03378,3510582,11565.0%
2025-09-02347,552500460,87275.4%
2025-08-29132,6768,741184,95971.7%
2025-08-28252,6179,695348,71372.4%
2025-08-27443,8565,237598,98974.1%
2025-08-2669,1622,101120,96257.2%
2025-08-2571,407095,99574.4%
2025-08-2251,4820129,36439.8%
2025-08-2150,2226,82584,07859.7%
2025-08-2065,4951,000121,84253.8%
2025-08-19186,8333,710256,46772.8%
2025-08-18113,0785,618265,95442.5%
2025-08-15112,3860206,42054.4%
2025-08-14122,6050253,39348.4%
2025-08-13149,4750313,24747.7%
2025-08-1292,1210220,66841.7%
2025-08-1197,201278354,90327.4%
2025-08-08130,7290412,44731.7%
2025-08-0760,6910124,46748.8%
2025-08-06157,5080315,62649.9%
2025-08-0576,490107253,97930.1%
2025-08-0493,0110337,79827.5%
2025-08-01114,4670258,99944.2%
2025-07-31107,7060281,92338.2%
2025-07-3084,5564,853273,22330.9%
2025-07-29428,7919,57311,399,6913.8%
2025-07-2877,7890204,39138.1%
2025-07-2597,41134171,61156.8%
2025-07-2454,925080,94567.9%
2025-07-23130,1770426,52530.5%
2025-07-2263,8820150,84842.3%
2025-07-2198,9510199,24349.7%
2025-07-18113,5480149,79775.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy